Request Brochure

Covid 19 – We are fully operational during this time, taking calls 8am-8pm 7 days a week.

Health Hub

Umbilical cord stem cells could improve survival chances for patients with Covid

A new study suggests umbilical cord stem cells found in the cord of new born babies implanted into Covid patients could improve survival chances.  The study was carried out in the USA by scientists at the University of Miami Miller School of Medicine where researchers have reported a 91 per cent survival rate in seriously […]

Read Article

A background on the scope and potential for cord blood and perinatal tissue therapies

Since the late 1980s, umbilical cord blood and related birthing tissues have evolved from medical waste to a rich source of blood stem cells. These can be transplanted to restore normal blood and immune cell development and function in blood diseases such as leukemia and lymphoma, certain inherited genetic disorders, bone marrow failure and immune deficiency diseases. 

Read Article

What makes cord blood special?

What makes cord blood special? As we approach World Cord Blood Day on November 17, we look at why umbilical cord blood banking is attracting so much attention.

Read Article

Placenta banking services should be viewed with caution

There is very little scientific evidence for the value of banking placenta cells clinically. Biovault is always excited about developments in tissue and cell banking and we keep a close eye on innovation within our Industry. However, in line with our ethical and cautious approach, fostered through our long working relationship with the NHS we […]

Read Article

Your baby’s cord blood is amazing

Why you should consider banking your baby’s cord blood Cord blood is the leftover blood in the umbilical cord after birth, and cord tissue is the cord itself. Both contain powerful stem cells that could be used to potentially treat a variety of medical conditions. Cord blood is rich in stem cells that can morph […]

Read Article

COVID-19 and pregnancy – an update from the 2020 Cord Blood Connect

Research suggests that COVID-19 is not present in birthing tissues collected at the time of birth. Welcome to our Friday update where we have news from the recent 2020 Cord Blood Connect attended by Biovault Family’s CEO Kate Sneddon. Usually an annual conference held in Miami, this year’s event moved to a virtual platform allowing […]

Read Article

Innovation, creativity and collaboration: Building a Health Startup in a weekend

Biovault’s CEO Kate Sneddon is set to judge Techstars Startup Weekend in Plymouth. Here’s why entrepreneurship in Health & Wellbeing matters Beginning on Friday, April 26 – 28, 2019 Techstars Startup Weekend Plymouth will take place at the beautiful Royal William Yard. Techstars Startup weekend provides a place to look for a team, create a […]

Read Article

Can cord blood treat leukaemia patients in relapse?

In the first major study of cord blood transplantation for secondary acute myeloid leukaemia 40% of patients are “rescued” from the disease. The results of world’s first major study into the use of cord blood transplantation (CBT) to treat secondary acute myeloid leukaemia (sAML), were published in December 2018. 146 patients participated in the test. […]

Read Article

State of the science: 6 conditions that may soon be treated with stem cells

From easing creaky knees to mending a damaged heart, it seems that scientists are on the brink of using stem cells to revolutionise treating a range of conditions. These master cells are essentially the building blocks of human tissue, and some have the capacity to turn into any type of specialist cell, such as skin, […]

Read Article